NFE2L2 and ovarian cancer: NFE2L2 knockdown or gene disruption also sensitizes lung adenocarcinoma cells, hepatoma cells, rat and human glioma cells, and ovarian cancer cells to ferroptosis (50, 109, 110, 111).